Aperiodic electrophysiological activity in preterm infants is linked to subsequent autism risk

Lauren C Shuffrey1,2, Nicolò Pini1,2, Mandy Potter3

  • 1Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA.

Insights

Aperiodic activity in infant EEG may predict autism risk in preterm infants. This study found no link between EEG and later cognitive development, highlighting new research avenues for early autism detection.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Genetics

Background:

  • Preterm infants face higher autism spectrum disorder (ASD) risks.
  • Identifying early neurodevelopmental markers in preterm infants is crucial.
  • Current research on predictive markers for ASD in preterm infants is limited.

Purpose of the Study:

  • To investigate electroencephalography (EEG) parameters as potential early markers for autism risk in preterm infants.
  • To examine the association between infant EEG activity and later autism risk and cognitive ability.
  • To explore aperiodic EEG activity and power spectral density (PSD) slope in relation to neurodevelopmental outcomes.

Main Methods:

  • Seventy-one preterm infants (25–36 weeks gestation) underwent EEG during sleep (39–41 weeks postmenstrual age).
  • EEG parameters included absolute power and PSD slope (aperiodic activity).
  • Cognitive and social-emotional development were assessed at ~3 years using Bayley Scales and BITSEA.

Main Results:

  • Aperiodic EEG activity at multiple electrode sites was associated with increased autism risk at three years.
  • Rhythmic oscillatory activity, PSD slope, and absolute EEG power were not linked to autism risk.
  • No EEG parameters predicted cognitive development outcomes.

Conclusions:

  • Infant EEG's aperiodic activity shows potential as a predictive marker for autism risk in preterm populations.
  • This finding suggests focusing on specific EEG patterns beyond traditional rhythmic activity for early ASD detection.
  • Further research is needed to validate these markers in diverse, high-risk infant groups.

Related Concept Videos